Skip to main content
Top
Published in: BMC Nephrology 1/2022

Open Access 01-12-2022 | Acute Kidney Injury | Case report

A suspected case of hyponatraemia induced rhabdomyolysis: a case report

Authors: Edward Reakes, Douglas Drak, David Gracey

Published in: BMC Nephrology | Issue 1/2022

Login to get access

Abstract

Background

Hyponatraemia is a documented but under-recognised cause of rhabdomyolysis, with the contrasting treatment strategies for the two conditions posing a unique challenge. Balancing the need for aggressive fluid replacement for the treatment of rhabdomyolysis, with the risk of rapidly correcting hyponatraemia is imperative.

Case presentation

A 52-year-old gentleman with a background of HIV infection and hypertension presented with seizures following methamphetamine use, acute water intoxication, and thiazide use. He was found to have severe hyponatraemia, and following initial correction with hypertonic saline, was commenced on a fluid restriction. After two days he developed abdominal wall and thigh pain, along with oliguria. Laboratory data demonstrated markedly elevated creatine kinase levels and deteriorating renal function. A diagnosis of rhabdomyolysis and severe acute kidney injury was made and aggressive fluid replacement commenced, leading to full resolution of the hyponatraemia, rhabdomyolysis and acute kidney injury.

Conclusion

Hyponatraemia-induced rhabdomyolysis is rare but can cause significant morbidity and mortality if left untreated. Physicians should consider measuring creatine kinase levels in all patients presenting with severe hyponatraemia, particularly in the presence of other risk factors for rhabdomyolysis. Fluid replacement strategies must be considered in relation to the relative onset and risk of over-correcting hyponatraemia.
Literature
1.
go back to reference Katsarou A, Singh S. Hyponatraemia associated rhabdomyolysis following water intoxication. Case Reports. 2010;2010:bcr0220102720. Katsarou A, Singh S. Hyponatraemia associated rhabdomyolysis following water intoxication. Case Reports. 2010;2010:bcr0220102720.
2.
go back to reference Fadus MC. Rhabdomyolysis Complicating Psychogenic Polydipsia. Am J Psychiatry Residents J. 2018; Fadus MC. Rhabdomyolysis Complicating Psychogenic Polydipsia. Am J Psychiatry Residents J. 2018;
3.
go back to reference Cronin RE. Psychogenic polydipsia with hyponatremia: report of eleven cases. Am J Kidney Dis. 1987;9(5):410–6.CrossRef Cronin RE. Psychogenic polydipsia with hyponatremia: report of eleven cases. Am J Kidney Dis. 1987;9(5):410–6.CrossRef
4.
go back to reference Bennett M, Fitzpatrick G, Donnelly M. Rhabdomyolysis associated with polydipsia induced hyponatraemia. Case Reports. 2011, 2011:bcr0820114659. Bennett M, Fitzpatrick G, Donnelly M. Rhabdomyolysis associated with polydipsia induced hyponatraemia. Case Reports. 2011, 2011:bcr0820114659.
5.
go back to reference Aguiar DT, Monteiro C, Coutinho P. Recurrent rhabdomyolysis secondary to hyponatremia in a patient with primary psychogenic polydipsia. Rev Bras Ter Intensiva. 2015;27:77–81.CrossRef Aguiar DT, Monteiro C, Coutinho P. Recurrent rhabdomyolysis secondary to hyponatremia in a patient with primary psychogenic polydipsia. Rev Bras Ter Intensiva. 2015;27:77–81.CrossRef
6.
go back to reference Kennedy L, Nagiah S. A case of severe rhabdomyolysis associated with secondary adrenal insufficiency and autoimmune hepatitis. BMJ Case Reports CP. 2019;12(3):e227343.CrossRef Kennedy L, Nagiah S. A case of severe rhabdomyolysis associated with secondary adrenal insufficiency and autoimmune hepatitis. BMJ Case Reports CP. 2019;12(3):e227343.CrossRef
7.
go back to reference Lau SY, Yong TY. rhabdomyolysis in acute primary adrenal insufficiency complicated by severe hyponatraemia. Intern Med. 2012;51:2371–4.CrossRef Lau SY, Yong TY. rhabdomyolysis in acute primary adrenal insufficiency complicated by severe hyponatraemia. Intern Med. 2012;51:2371–4.CrossRef
8.
go back to reference Fernando S, Sivagnanam F, Rathish D. A compulsive act of excess water intake leading to hyponatraemia and rhabdomyolysis: a case report. Int J Emerg Med. 2019;12(1):34.CrossRef Fernando S, Sivagnanam F, Rathish D. A compulsive act of excess water intake leading to hyponatraemia and rhabdomyolysis: a case report. Int J Emerg Med. 2019;12(1):34.CrossRef
9.
go back to reference Secombe P, Milne C. Hyponatraemia-induced rhabdomyolysis complicated by anuric acute kidney injury: a renal replacement conundrum. Case Rep. 2016;2016:bcr2016218198. Secombe P, Milne C. Hyponatraemia-induced rhabdomyolysis complicated by anuric acute kidney injury: a renal replacement conundrum. Case Rep. 2016;2016:bcr2016218198.
10.
go back to reference Peled M, Dolkart O, Finn T, et al. No association between hyponatremia and rhabdomyolysis in rats. J Emerg Med. 2014;47:472–8.CrossRef Peled M, Dolkart O, Finn T, et al. No association between hyponatremia and rhabdomyolysis in rats. J Emerg Med. 2014;47:472–8.CrossRef
11.
go back to reference Bosch X, Poch E, Grau JM. Rhabdomyolysis and acute kidney injury. N Engl J Med. 2009;361(1):62–72.CrossRef Bosch X, Poch E, Grau JM. Rhabdomyolysis and acute kidney injury. N Engl J Med. 2009;361(1):62–72.CrossRef
12.
go back to reference Kleinschmidt-Demasters BK, Rojiani AM, Filley CM. Central and extrapontine myelinolysis: then … and now. J Neuropathol Exp Neurol. 2006;65(1):1.CrossRef Kleinschmidt-Demasters BK, Rojiani AM, Filley CM. Central and extrapontine myelinolysis: then … and now. J Neuropathol Exp Neurol. 2006;65(1):1.CrossRef
13.
go back to reference Huerta-Alardín AL, Varon J, Marik PE. Bench-to-bedside review: Rhabdomyolysis–an overview for clinicians. Crit Care. 2004;9(2):158.CrossRef Huerta-Alardín AL, Varon J, Marik PE. Bench-to-bedside review: Rhabdomyolysis–an overview for clinicians. Crit Care. 2004;9(2):158.CrossRef
14.
go back to reference Eilert RJ, Kliewer ML. Methamphetamine-induced rhabdomyolysis. Int Anesthesiol Clin. 2011;49(2):52–6.CrossRef Eilert RJ, Kliewer ML. Methamphetamine-induced rhabdomyolysis. Int Anesthesiol Clin. 2011;49(2):52–6.CrossRef
15.
go back to reference Isoardi KZ, Mudge DW, Harris K, Dimeski G, Buckley NA. Methamphetamine intoxication and acute kidney injury: A prospective observational case series. Nephrology (Carlton). 2020;25(10):758–64.CrossRef Isoardi KZ, Mudge DW, Harris K, Dimeski G, Buckley NA. Methamphetamine intoxication and acute kidney injury: A prospective observational case series. Nephrology (Carlton). 2020;25(10):758–64.CrossRef
16.
go back to reference Chesson AL, Kasarskis EJ, Small VW. Postictal elevation of serum creatine kinase level. Arch Neurol. 1983;40(5):315–7.CrossRef Chesson AL, Kasarskis EJ, Small VW. Postictal elevation of serum creatine kinase level. Arch Neurol. 1983;40(5):315–7.CrossRef
17.
go back to reference Nass RD, Meiling S, Andrié RP, Elger CE, Surges R. Laboratory markers of cardiac and metabolic complications after generalized tonic-clonic seizures. BMC Neurol. 2017;17(1):187.CrossRef Nass RD, Meiling S, Andrié RP, Elger CE, Surges R. Laboratory markers of cardiac and metabolic complications after generalized tonic-clonic seizures. BMC Neurol. 2017;17(1):187.CrossRef
18.
go back to reference Godinho R, Bugnon S, Gracin T, Tataw J. Severe rhabdomyolysis-induced acute kidney injury following concomitant use of Genvoya®(EVG/COBI/FTC/TAF) and simvastatin; a case report. BMC Nephrol. 2019;20(1):1–5.CrossRef Godinho R, Bugnon S, Gracin T, Tataw J. Severe rhabdomyolysis-induced acute kidney injury following concomitant use of Genvoya®(EVG/COBI/FTC/TAF) and simvastatin; a case report. BMC Nephrol. 2019;20(1):1–5.CrossRef
19.
go back to reference Zembower TR, Gerzenshtein L, Coleman K, et al. Severe rhabdomyolysis associated with raltegravir use. AIDS. 2008;22:1382–4.CrossRef Zembower TR, Gerzenshtein L, Coleman K, et al. Severe rhabdomyolysis associated with raltegravir use. AIDS. 2008;22:1382–4.CrossRef
20.
go back to reference Dori L, Buonomini AR, Viscione M, et al. A case of rhabdomyolysis associated with raltegravir use. AIDS. 2010;24:473–5.CrossRef Dori L, Buonomini AR, Viscione M, et al. A case of rhabdomyolysis associated with raltegravir use. AIDS. 2010;24:473–5.CrossRef
21.
go back to reference Masia M, Enriquez R, Sirvent A, et al. Severe acute renal failure associated with rhabdomyolysis during treatment with raltegravir. A call for caution J Infect. 2010;61:189–90. Masia M, Enriquez R, Sirvent A, et al. Severe acute renal failure associated with rhabdomyolysis during treatment with raltegravir. A call for caution J Infect. 2010;61:189–90.
22.
go back to reference Croce F, Vitello P, Dalla Pria A, et al. Severe raltegravir-associated rhabdo- myolysis: a case report and review of the literature. Int J STD AIDS. 2010;21:783–5.CrossRef Croce F, Vitello P, Dalla Pria A, et al. Severe raltegravir-associated rhabdo- myolysis: a case report and review of the literature. Int J STD AIDS. 2010;21:783–5.CrossRef
23.
go back to reference Saad M, Casado-Castillo F, Kelly P. Case report of Triumeq (abacavir/dolutegravir/lamivudine) associated rhabdomyolysis in a human immunodeficiency virus (HIV) infected patient. Medicine. 2019;98(17):e15149. Saad M, Casado-Castillo F, Kelly P. Case report of Triumeq (abacavir/dolutegravir/lamivudine) associated rhabdomyolysis in a human immunodeficiency virus (HIV) infected patient. Medicine. 2019;98(17):e15149.
24.
go back to reference Lee FJ, Carr A. Tolerability of HIV integrase inhibitors. Curr Opin HIV AIDS. 2012;7(5):422–8.CrossRef Lee FJ, Carr A. Tolerability of HIV integrase inhibitors. Curr Opin HIV AIDS. 2012;7(5):422–8.CrossRef
Metadata
Title
A suspected case of hyponatraemia induced rhabdomyolysis: a case report
Authors
Edward Reakes
Douglas Drak
David Gracey
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2022
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-022-02787-7

Other articles of this Issue 1/2022

BMC Nephrology 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.